Skip to Content

Can a PDE4-inhibitor be the next approved drug for the treatment of hidradenitis suppurativa?

In this MEDtalk, Elisabeth H. Taudorf, MD, Zealand University Hospital takes a deep dive into a patient case with severe HS. The patient was treated with a PDE-4 inhibitor. In this phase-II study, the focus was on reduced pain and increased quality of life following treatment with the pde4-inhibitor.

Elisabeth Hjardem Taudorf

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top